186 related articles for article (PubMed ID: 37069142)
1. Phosphorylation and stabilization of EZH2 by DCAF1/VprBP trigger aberrant gene silencing in colon cancer.
Ghate NB; Kim S; Shin Y; Kim J; Doche M; Valena S; Situ A; Kim S; Rhie SK; Lenz HJ; Ulmer TS; Mumenthaler SM; An W
Nat Commun; 2023 Apr; 14(1):2140. PubMed ID: 37069142
[TBL] [Abstract][Full Text] [Related]
2. VprBP directs epigenetic gene silencing through histone H2A phosphorylation in colon cancer.
Ghate NB; Kim S; Spiller E; Kim S; Shin Y; Rhie SK; Smbatyan G; Lenz HJ; Mumenthaler SM; An W
Mol Oncol; 2021 Oct; 15(10):2801-2817. PubMed ID: 34312968
[TBL] [Abstract][Full Text] [Related]
3. VprBP/DCAF1 Triggers Melanomagenic Gene Silencing through Histone H2A Phosphorylation.
Shin Y; Kim S; Liang G; Ulmer TS; An W
Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37760992
[TBL] [Abstract][Full Text] [Related]
4. VprBP/DCAF1 triggers melanomagenic gene silencing through histone H2A phosphorylation.
Shin Y; Kim S; Liang G; Ulmer TS; An W
Res Sq; 2023 Jul; ():. PubMed ID: 37293029
[TBL] [Abstract][Full Text] [Related]
5. VprBP/DCAF1 regulates p53 function and stability through site-specific phosphorylation.
Ghate NB; Kim S; Mehmood R; Shin Y; Kim K; An W
Oncogene; 2023 Apr; 42(17):1405-1416. PubMed ID: 37041410
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity.
Özeş AR; Pulliam N; Ertosun MG; Yılmaz Ö; Tang J; Çopuroğlu E; Matei D; Özeş ON; Nephew KP
Oncogene; 2018 Jun; 37(26):3589-3600. PubMed ID: 29576612
[TBL] [Abstract][Full Text] [Related]
7. EZH2 is involved in silencing of WNT5A during epithelial-mesenchymal transition of colon cancer cell line.
Tao J; Shi L; Huang L; Shi H; Chen H; Wang Y; Wang T
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2211-2219. PubMed ID: 28748258
[TBL] [Abstract][Full Text] [Related]
8. EZH2 regulates H2B phosphorylation and elevates colon cancer cell autophagy.
Liu Z; Yang L; Zhong C; Zhou L
J Cell Physiol; 2020 Feb; 235(2):1494-1503. PubMed ID: 31283006
[TBL] [Abstract][Full Text] [Related]
9. The EZH2- H3K27me3-DNMT1 complex orchestrates epigenetic silencing of the wwc1 gene, a Hippo/YAP pathway upstream effector, in breast cancer epithelial cells.
Liu X; Li C; Zhang R; Xiao W; Niu X; Ye X; Li Z; Guo Y; Tan J; Li Y
Cell Signal; 2018 Nov; 51():243-256. PubMed ID: 30121333
[TBL] [Abstract][Full Text] [Related]
10. GSK3β inactivation promotes the oncogenic functions of EZH2 and enhances methylation of H3K27 in human breast cancers.
Ko HW; Lee HH; Huo L; Xia W; Yang CC; Hsu JL; Li LY; Lai CC; Chan LC; Cheng CC; Labaff AM; Liao HW; Lim SO; Li CW; Wei Y; Nie L; Yamaguchi H; Hung MC
Oncotarget; 2016 Aug; 7(35):57131-57144. PubMed ID: 27494834
[TBL] [Abstract][Full Text] [Related]
11. The deletion of the protein phosphatase 1 regulator NIPP1 in testis causes hyperphosphorylation and degradation of the histone methyltransferase EZH2.
Ferreira M; Verbinnen I; Fardilha M; Van Eynde A; Bollen M
J Biol Chem; 2018 Nov; 293(47):18031-18039. PubMed ID: 30305391
[TBL] [Abstract][Full Text] [Related]
12. EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers.
Au SL; Wong CC; Lee JM; Wong CM; Ng IO
PLoS One; 2013; 8(6):e68226. PubMed ID: 23826380
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling.
Song H; Yu Z; Sun X; Feng J; Yu Q; Khan H; Zhu X; Huang L; Li M; Mok MTS; Cheng ASL; Gao Y; Feng H
EBioMedicine; 2018 Sep; 35():155-166. PubMed ID: 30150059
[TBL] [Abstract][Full Text] [Related]
14. The noncanonical role of EZH2 in cancer.
Huang J; Gou H; Yao J; Yi K; Jin Z; Matsuoka M; Zhao T
Cancer Sci; 2021 Apr; 112(4):1376-1382. PubMed ID: 33615636
[TBL] [Abstract][Full Text] [Related]
15. Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2.
Gnani D; Romito I; Artuso S; Chierici M; De Stefanis C; Panera N; Crudele A; Ceccarelli S; Carcarino E; D'Oria V; Porru M; Giorda E; Ferrari K; Miele L; Villa E; Balsano C; Pasini D; Furlanello C; Locatelli F; Nobili V; Rota R; Leonetti C; Alisi A
Cell Death Differ; 2017 May; 24(5):889-902. PubMed ID: 28338656
[TBL] [Abstract][Full Text] [Related]
16. Aberrant Activation of β-Catenin Signaling Drives Glioma Tumorigenesis via USP1-Mediated Stabilization of EZH2.
Ma L; Lin K; Chang G; Chen Y; Yue C; Guo Q; Zhang S; Jia Z; Huang TT; Zhou A; Huang S
Cancer Res; 2019 Jan; 79(1):72-85. PubMed ID: 30425057
[TBL] [Abstract][Full Text] [Related]
17. EZH2-mediated H3K27me3 enrichment on the lncRNA MEG3 promoter regulates the growth and metastasis of glioma cells by regulating miR-21-3p.
Qin WX; Shi Y; Zhu D; Li YP; Chen YH; Cui J; Cui GY; Pan JX; Ren ZY
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3204-3214. PubMed ID: 32271438
[TBL] [Abstract][Full Text] [Related]
18. EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion.
Yi X; Guo J; Guo J; Sun S; Yang P; Wang J; Li Y; Xie L; Cai J; Wang Z
Sci Rep; 2017 Jun; 7(1):3568. PubMed ID: 28620234
[TBL] [Abstract][Full Text] [Related]
19. EZH2 mediates lidamycin-induced cellular senescence through regulating p21 expression in human colon cancer cells.
Sha MQ; Zhao XL; Li L; Li LH; Li Y; Dong TG; Niu WX; Jia LJ; Shao RG; Zhen YS; Wang Z
Cell Death Dis; 2016 Nov; 7(11):e2486. PubMed ID: 27882937
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of EZH2 by CDK1 and CDK2: a possible regulatory mechanism of transmission of the H3K27me3 epigenetic mark through cell divisions.
Zeng X; Chen S; Huang H
Cell Cycle; 2011 Feb; 10(4):579-83. PubMed ID: 21278485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
